U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07178158) titled 'Enhancing Addiction Treatment Through Psychoeducation' on July 25.
Brief Summary: Addiction is a brain disorder characterized by a broad range of both apparent and subtle cognitive impairments in attention, memory, executive functions, and decision-making. These cognitive problems are clinically significant and may contribute to poor treatment outcomes in people with Substance Use Disorders (SUDs), such as a high risk of dropout, low treatment compliance, and shorter periods of abstinence. Studies on cognitive function in SUDs reveal that chronic use of drugs and alcohol can also negatively affect another crucial component of cogni...